Arocaine-A DC Injection

Introduction

Arocaine-A DC Injection 4%+0.001% is a combination used primarily as a local anesthetic in dental procedures. Articaine is an amide-type anesthetic that provides local anesthesia, while Epinephrine is a vasoconstrictor that helps to prolong the effect of the anesthetic by constricting blood vessels at the site of injection.

Uses

This combination is used for:

Local anesthesia in dental procedures, such as extractions, root canals, and fillings.
Providing anesthesia in minor surgical procedures where local anesthesia is required.

Brand Name	Arocaine-A DC
Type	Injection
Weight	4%+0.001%
Generic	Articaine Hydrochloride + Epinephrine
Manufacturer	Jayson Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Articaine works by blocking sodium channels in nerve cells, preventing the generation and conduction of nerve impulses. This results in a loss of sensation in the area where it is applied. Epinephrine works by constricting blood vessels, which decreases blood flow to the area, thereby prolonging the duration of anesthesia and reducing bleeding during the procedure.

How Long Does It Take to Work?

Articaine Hydrochloride typically begins to take effect within 1 to 5 minutes after injection. The onset time may vary slightly based on the exact location of the injection and the patient's individual response. The effects can last from 30 minutes to several hours, depending on the dosage and area treated.

Absorption

After injection, Articaine is absorbed into the bloodstream from the site of administration. The absorption rate is influenced by the presence of Epinephrine, which reduces blood flow at the injection site and therefore slows the systemic absorption of Articaine, extending its anesthetic effects.

Route of Elimination

Articaine is metabolized primarily in the liver, and its metabolites are excreted through the urine. Epinephrine is metabolized by monoamine oxidase and catechol-O-methyltransferase, and is also excreted in the urine.

Dosage

The dosage of Arocaine-A DC Injection 4%+0.001% is typically adjusted based on the specific procedure and patient needs. A common concentration used is 4% Articaine with 1:100,000 or 1:200,000 Epinephrine. The total dose administered should not exceed 7 mg/kg of Articaine, and the total dose of Epinephrine should be carefully monitored to avoid systemic effects.

Administration

This combination is administered via injection into the area requiring anesthesia. The injection is typically performed using a dental syringe, and the location of the injection depends on the specific dental procedure being performed.

Side Effects

Common side effects include:

Injection site pain or swelling.
Temporary numbness in the area of injection.
Allergic reactions, though rare.

Serious side effects may include:

Systemic toxicity if large amounts are absorbed into the bloodstream, potentially causing seizures or cardiovascular effects.
Adverse reactions due to Epinephrine, such as increased heart rate or blood pressure.

Toxicity

Signs of toxicity may include:

Seizures or convulsions.
Severe cardiovascular effects such as arrhythmias or hypertension.
Respiratory depression.

If symptoms of toxicity occur, seek immediate medical attention. Treatment may include supportive care and medications to manage symptoms.

Precautions

Precautions include:

Monitoring patients for signs of systemic toxicity, particularly in cases of high doses or rapid absorption.
Using caution in patients with cardiovascular conditions or hypertension due to the presence of Epinephrine.
Ensuring proper technique to avoid injection into blood vessels.

Interaction

Interactions may include:

Potential interactions with other local anesthetics or vasoconstrictors used concurrently.
Drugs that affect cardiovascular function, as Epinephrine can influence blood pressure and heart rate.

Disease Interaction

Use with caution in patients with:

Cardiovascular diseases, including hypertension, heart disease, or arrhythmias.
Liver or kidney dysfunction, which may affect drug metabolism and clearance.

Drug Interaction

Drug interactions include:

Beta-blockers and other antihypertensives may interact with Epinephrine, potentially altering its effects on blood pressure and heart rate.
Other medications that influence liver enzymes could affect the metabolism of Articaine.

Food Interactions

There are no significant food interactions reported with Arocaine-A DC Injection 4%+0.001%. However, it is generally advisable to avoid alcohol before and after the procedure, as it can affect the overall reaction to anesthesia.

Pregnancy Use

Articaine and Epinephrine should be used during pregnancy only if clearly needed. Articaine is classified as Category C by the FDA, meaning that risk cannot be ruled out. Consult a healthcare provider to evaluate the potential benefits and risks during pregnancy.

Lactation Use

Both Articaine and Epinephrine are excreted in breast milk in small amounts. While generally considered safe for use during lactation, consult a healthcare provider to discuss any potential risks and to determine if any precautions are necessary.

Acute Overdose

In the event of an acute overdose, symptoms may include severe CNS effects (e.g., seizures), cardiovascular effects (e.g., arrhythmias), or systemic reactions to Epinephrine. Treatment involves supportive care, monitoring, and symptomatic management.

Contraindication

Contraindications include:

Known hypersensitivity to Articaine, Epinephrine, or any components of the formulation.
Severe cardiovascular conditions where Epinephrine may exacerbate symptoms.
Severe liver or kidney dysfunction that may affect drug metabolism and clearance.

Use Direction

Follow the specific dosage and administration instructions provided by the healthcare provider. For optimal results, ensure the injection is administered correctly at the appropriate site and avoid overuse.

Storage Conditions

Store Arocaine-A DC Injection 4%+0.001% at room temperature, away from light and moisture. Keep it in its original container and ensure it is secure to prevent accidental exposure.

Volume of Distribution

The volume of distribution for Articaine varies depending on the formulation and individual patient characteristics. Generally, it distributes widely throughout the body, with significant amounts reaching the target tissues at the site of injection.

Half Life

The half-life of Articaine is approximately 0.5 to 1.5 hours. Epinephrine has a much shorter half-life, typically less than 5 minutes due to rapid metabolism and clearance.

Clearance

Articaine is cleared primarily through hepatic metabolism, with renal excretion of its metabolites. Epinephrine is metabolized by the liver and excreted in the urine. The clearance rates of both drugs can be influenced by liver and kidney function.

See in details version Arocaine-A DC Injection 4%+0.001% also Arocaine-A DC Injection 4%+0.001% in bangla